Literature DB >> 6847240

Circulating IgA- and IgG-class antigliadin antibodies in dermatitis herpetiformis detected by enzyme-linked immunosorbent assay.

E Vainio, K Kalimo, T Reunala, M Viander, T Palosuo.   

Abstract

A sensitive and technically simple enzyme-linked immunosorbent assay (ELISA) was developed to demonstrate circulating IgA- and IgG-class antibodies to gliadin, a component of wheat gluten. Serum samples from 24 patients with dermatitis herpetiformis (DH), 5 with coeliac disease (CD) and 75 normal controls were analysed. Antigliadin antibodies (AGA) of the IgA class were detected in 71% of DH patients, all of the CD patients and 19% of the controls. IgG-AGA was found in over 90% of DH patients and controls and in all of the CD patients. The mean ELISA values of both IgA- and IgG-class AGA were significantly higher in DH patients than in the controls. The occurrence of circulating IgA-class AGA is compatible with the hypothesis that these antibodies can be deposited in the skin, e.g. as immune complexes, or due to cross-reactivity of gliadin and dermal reticulin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6847240     DOI: 10.1007/bf00516548

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  15 in total

1.  SIGNIFICANCE OF ANTIBODIES TO DIETARY PROTEINS IN THE SERUMS OF PATIENTS WITH NONTROPICAL SPRUE.

Authors:  R M KIVEL; D H KEARNS; D LIEBOWITZ
Journal:  N Engl J Med       Date:  1964-10-08       Impact factor: 91.245

2.  Rheumatoid factor in sera of dermatitis herpetiformis patients.

Authors:  K Kalimo
Journal:  Br J Dermatol       Date:  1978-01       Impact factor: 9.302

3.  Antireticulin antibody: incidence and diagnostic significance.

Authors:  P P Seah; L Fry; E J Holborow; M A Rossiter; W F Doe; A F Magalhaes; A V Hoffbrand
Journal:  Gut       Date:  1973-04       Impact factor: 23.059

4.  Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal.

Authors:  L Fry; P P Seah; D J Riches; A V Hoffbrand
Journal:  Lancet       Date:  1973-02-10       Impact factor: 79.321

5.  Circulating immune complexes of IgA type in dermatitis herpetiformis.

Authors:  J J Zone; B A LaSalle; T T Provost
Journal:  J Invest Dermatol       Date:  1980-08       Impact factor: 8.551

6.  Gluten-free diet in dermatitis herpetiformis. II. Morphological and immunological findings in the skin and small intestine of 12 patients and matched controls.

Authors:  T Reunala
Journal:  Br J Dermatol       Date:  1978-01       Impact factor: 9.302

7.  Dermatitis herpetiformis: the skin and the gut.

Authors:  S I Katz; R P Hall; T J Lawley; W Strober
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

8.  Wheat grains: a substrate for the determination of gluten antibodies in serum of gluten-sensitive patients.

Authors:  K P Eterman; W T Hekkens; A S Pena; P H Lems-van Kan; T E Feltkamp
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

9.  Multiple immune complexes and hypocomplementaemia in dermatitis herpetiformis and coeliac disease.

Authors:  I Mohammed; E J Holborow; L Fry; B R Thompson; A V Hoffbrand; J S Stewart
Journal:  Lancet       Date:  1976-09-04       Impact factor: 79.321

10.  IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases.

Authors:  R P Hall; T J Lawley; J A Heck; S I Katz
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

View more
  9 in total

1.  Screening of diabetic children for coeliac disease with antigliadin antibodies and HLA typing.

Authors:  G Barera; C Bianchi; L Calisti; F Cerutti; F Dammacco; E Frezza; M T Illeni; L Mistura; M Pocecco; F Prisco
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

2.  Serum antibodies to wheat germ agglutinin and gluten in patients with dermatitis herpetiformis.

Authors:  L M Sollid; H Scott; J Kolberg; P Brandtzaeg
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

3.  Celiac disease without villous atrophy: revision of criteria called for.

Authors:  K Kaukinen; M Mäki; J Partanen; H Sievänen; P Collin
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

4.  Postpubertal gluten challenge in coeliac disease.

Authors:  M Mäki; M L Lähdeaho; O Hällström; M Viander; J K Visakorpi
Journal:  Arch Dis Child       Date:  1989-11       Impact factor: 3.791

5.  Infertility and coeliac disease.

Authors:  P Collin; S Vilska; P K Heinonen; O Hällström; P Pikkarainen
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

6.  A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.

Authors:  Eric Marietta; Kay Black; Michael Camilleri; Patricia Krause; Roy S Rogers; Chella David; Mark R Pittelkow; Joseph A Murray
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

7.  Humoral beta-cell autoimmunity is rare in patients with the congenital rubella syndrome.

Authors:  H Viskari; J Paronen; P Keskinen; S Simell; B Zawilinska; I Zgorniak-Nowosielska; S Korhonen; J Ilonen; O Simell; A-M Haapala; M Knip; H Hyöty
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

8.  Dermatitis herpetiformis: relation between circulating immune complexes, small-intestinal mucosal status, and immunohistopathological findings.

Authors:  E Szabó; S Husz; T Várkonyi; Z F Kiss
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 9.  Serological Diagnosis of Autoimmune Bullous Skin Diseases.

Authors:  Sandra Saschenbrecker; Ingolf Karl; Lars Komorowski; Christian Probst; Cornelia Dähnrich; Kai Fechner; Winfried Stöcker; Wolfgang Schlumberger
Journal:  Front Immunol       Date:  2019-08-20       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.